Monte Rosa Therapeutics Inc Cash Flow Reinvestment Rate
Monte Rosa Therapeutics Inc cash flow reinvestment rate. Monte Rosa Therapeutics Inc (GLUE) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting $38.79 Million (capex $651.00K plus investments $38.14 Million) from operating cash flow of $100.43 Million. Explore Monte Rosa Therapeutics Inc (GLUE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Monte Rosa Therapeutics Inc (2024–2024)
Cash flow reinvestment rate of Monte Rosa Therapeutics Inc from 2024 to 2024. Historical reinvestment intensity for Monte Rosa Therapeutics Inc across 1 annual periods. Explore Monte Rosa Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Monte Rosa Therapeutics Inc Cash Flow Reinvestment Rate by Year (2024–2024)
Monte Rosa Therapeutics Inc cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Monte Rosa Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Monte Rosa Therapeutics Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.15x | $48.44 Million | $42.00 Million | $3.99 Million | — |